Literature DB >> 8477811

An intermolecular mechanism of T cell help for the production of antibodies to the bacterial pathogen, Chlamydia trachomatis.

J E Allen1, R S Stephens.   

Abstract

Antibodies that neutralize infectivity are directed at the antigenically variant major outer membrane protein (MOMP) of Chlamydia trachomatis. A vaccine for chlamydia will need to include T cell determinants that elicit T helper (Th) cells which provide help to MOMP-specific B cells. A limited number of determinants on MOMP are able to elicit Th cells and sequence diversity in the MOMP molecule may alter T cell recognition of these determinants. We investigated whether two sequence invariant proteins of C. trachomatis that are both abundant and immunogenic could elicit T cell help for the production of antibody to MOMP. We found that outer membrane protein 2 (OMP2) but not outer membrane protein 3 (OMP3) was able to prime BALB/c mice for an anamnestic anti-MOMP response following boost with the intact organism. This demonstration of an intermolecular mechanism of T cell help in a bacterial system has important implications for the development of a chlamydial vaccine as well as the design of vaccines for other antigenically variant non-viral pathogens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477811     DOI: 10.1002/eji.1830230529

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis.

Authors:  V L Motin; L M de la Maza; E M Peterson
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Interaction of outer envelope proteins of Chlamydia psittaci GPIC with the HeLa cell surface.

Authors:  L M Ting; R C Hsia; C G Haidaris; P M Bavoil
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  Analysis of the humoral immune response to Chlamydia outer membrane protein 2.

Authors:  P Mygind; G Christiansen; K Persson; S Birkelund
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis.

Authors:  J C Goodall; H Beacock-Sharp; K H Deane; J S Gaston
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

5.  Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.

Authors:  J U Igietseme; A Murdin
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease.

Authors:  Alessandra Ciervo; Paolo Visca; Andrea Petrucca; Luigi Maria Biasucci; Attilio Maseri; Antonio Cassone
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

7.  A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.

Authors:  S C Knight; S Iqball; C Woods; A Stagg; M E Ward; M Tuffrey
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

Review 8.  Vaccines for bacterial sexually transmitted infections: a realistic goal?

Authors:  P F Sparling; C Elkins; P B Wyrick; M S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

9.  Protein antigens of Chlamydia psittaci present in infected cells but not detected in the infectious elementary body.

Authors:  D D Rockey; J L Rosquist
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

10.  Dissociation of immune determinants of outer membrane proteins of Chlamydia psittaci strain guinea pig inclusion conjunctivitis.

Authors:  T D Westbay; C C Dascher; R C Hsia; P M Bavoil; M Zauderer
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.